Rapport Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
RAPP Nasdaq 8731 https://www.rapportrx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Rapport Therapeutics Inc

Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences - Sep 5th, 2024 11:00 am
Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit - Aug 29th, 2024 11:00 am
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update - Aug 8th, 2024 11:00 am
3 Under-The-Radar Healthcare Stocks to Buy for Outsized Returns - Aug 6th, 2024 10:30 am
Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain - Jul 29th, 2024 11:00 am
Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement - Jun 12th, 2024 8:01 pm
Rapport Therapeutics Announces Pricing of Initial Public Offering - Jun 6th, 2024 10:54 pm